Login or sign up
For business

Calixa Therapeutics

4.1· 8 reviews
Average ratingGreat
4.1/ 5

Based on 8 reviews

538%
438%
325%
20%
10%
Ask AI

Ask AI about Calixa Therapeutics

Generated with AI from 8 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Michelle Morthorpe
Reviews 1

I have been a customer of Calixa Therapeutics for the past few months and I must say, their services are average. The website is user-friendly and their products have helped improve my health. However, I have had some issues with their customer service department. Overall, it's a decent company to do business with.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Calixa Therapeutics

Calixa Therapeutics, Inc. is a privately-held biopharmaceutical company focused on the development of a novel cephalosporin to address the expanding problem of multi-drug resistant organisms. Treatment of infections caused by resistant gram-negative bacteria, especially Pseudomonas aeruginosa, is recognized as an unmet medical need by the infectious diseases community.

Calixa’s lead product, CXA-101, is an IV formulation of a novel cephalosporin that has excellent potency especially against multi-drug resistant Pseudomonas aeruginosa, which differentiates it from other cephalosporins. No similar drug is known to be in development. Calixa plans to combine this product with a β-lactamase inhibitor; the combination product (CXA-201) has the potential to become the first-line therapeutic choice for hospitalized patients suffering from serious infection caused by gram-negative organisms.